These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 10119785)

  • 1. FDA considering new rules that may clamp down on early showings of works in progress.
    Wagner M
    Mod Healthc; 1992 Aug; 22(32):34. PubMed ID: 10119785
    [No Abstract]   [Full Text] [Related]  

  • 2. New US agent requirements.
    Donawa M
    Med Device Technol; 2002; 13(1):35-7. PubMed ID: 11921780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Europe and FDA agree to limited inspections.
    Fox JL
    Nat Biotechnol; 1997 Aug; 15(8):714-5. PubMed ID: 9333519
    [No Abstract]   [Full Text] [Related]  

  • 4. FDA import alert: a potentially devastating enforcement tool.
    Basile EM
    Med Device Technol; 1998 Apr; 9(3):34-8. PubMed ID: 10179199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical devices; medical device distributor reporting; opportunity for comments--FDA. Final rule; opportunity for comments.
    Fed Regist; 1993 Sep; 58(168):46514. PubMed ID: 10128334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ignore FDA reform at your peril.
    Fulton A
    AHIP Cover; 2007; 48(4):8, 54. PubMed ID: 17713032
    [No Abstract]   [Full Text] [Related]  

  • 7. Will new FDA rules hasten device approval?
    Hosp Mater Manage; 2003 Jul; 28(7):2, 16. PubMed ID: 12889277
    [No Abstract]   [Full Text] [Related]  

  • 8. Upon closer inspection. As the U.S. imports more drugs and devices, the FDA's overseas initiatives aim to head off trouble at the source.
    Rhea S
    Mod Healthc; 2009 Mar; 39(13):28-30. PubMed ID: 19405431
    [No Abstract]   [Full Text] [Related]  

  • 9. Transparent reaction. Suppliers oppose FDA move to disclose more data.
    Rhea S
    Mod Healthc; 2010 Jul; 40(30):16. PubMed ID: 20695055
    [No Abstract]   [Full Text] [Related]  

  • 10. Medical devices; intent to initiate proceedings to establish effective dates of requirement for premarket approval for 31 class III preamendments devices--FDA. Advance notice of proposed rulemaking.
    Fed Regist; 1989 Jan; 54(4):550-2. PubMed ID: 10291347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmaceuticals and medical devices: FDA oversight. End-of-year issue brief.
    Chaps NA
    Issue Brief Health Policy Track Serv; 2008 Jan; ():1-18. PubMed ID: 18345557
    [No Abstract]   [Full Text] [Related]  

  • 12. In search of a coherent framework: options for FDA oversight of genetic tests.
    Javitt GH
    Food Drug Law J; 2007; 62(4):617-52. PubMed ID: 18557224
    [No Abstract]   [Full Text] [Related]  

  • 13. Foreign establishment registration and listing. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2001 Nov; 66(228):59138-61. PubMed ID: 11776289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical devices; medical device reporting. Direct final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2005 Feb; 70(38):9516-28. PubMed ID: 15736310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safe Medical Devices Act: management guidance for hospital compliance with the new FDA requirements.
    Alder HC
    Hosp Technol Ser; 1993 Oct; 12(11):1-27. PubMed ID: 10129209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New FDA draft guidance on premarket submissions.
    Donawa ME
    Med Device Technol; 1999 Oct; 10(8):12-4. PubMed ID: 10724773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Group makes recommendations to speed FDA device approvals.
    Scott L
    Mod Healthc; 1993 May; 23(19):23. PubMed ID: 10125877
    [No Abstract]   [Full Text] [Related]  

  • 18. The new FDA combination products programme.
    Donawa M
    Med Device Technol; 2002 Oct; 13(8):25-8. PubMed ID: 12416330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MEDWATCH: the new FDA medical products reporting program.
    Kennedy DL
    Respir Care; 1993 Oct; 38(10):1077-80. PubMed ID: 10145891
    [No Abstract]   [Full Text] [Related]  

  • 20. Who would be affected if the FDA publishes mandatory standards? Or. . . Why Congress should get the FDA "off the hook".
    Miller MJ
    Med Instrum; 1986; 20(3):168. PubMed ID: 3724593
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.